Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
I-Mab Biopharma logo

I-Mab Biopharma

Recent Finacing

Series C

Recent Raise

$220M

I-Mab Biopharma is a Shanghai-based biotech developing biologics for immuno-oncology and immuno-inflammation, focusing on target biology, antibody engineering, preclinical and clinical development, and partnering with pharma and CROs.

Founded 2016
Shanghai, China
251-500
Publicly Traded
i-mabbiopharma.com

Highlights

Focus Areas

Biotechnology
Pharmaceutical
Product Research

Recent Investors

Ally Bridge Group logo
HOPU Investments logo
EDBI logo
CDH Investments logo
H
天士力资本 logo
Hony Capital logo
C-Bridge Capital logo

Financials

$220M

Total Raised

1

Funding round

8

Investors


Team

Upgrade to view the team

See the team members at I-Mab Biopharma.